Wellington Management Group LLP Uro Gen Pharma Ltd. Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Wellington Management Group LLP holds 125,298 shares of URGN stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,298

Previous 158,052 20.72%

Holding current value

$3.05 Million

Previous $2.17 Million 12.93%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$12.96 - $21.42 $424,491 - $701,590	-32,754 Reduced 20.72%	125,298 $2.45 Million
Q2 2025 Aug 14, 2025	BUY	$3.9 - $15.46 $38,898 - $154,198	9,974 Added 6.74%	158,052 $2.17 Million
Q1 2025 May 13, 2025	BUY	$9.27 - $12.13 $1.37 Million - $1.8 Million	148,078 New	148,078 $1.64 Million
Q4 2024 Feb 12, 2025	BUY	$10.52 - $13.11 $101,549 - $126,550	9,653 Added 7.03%	146,953 $1.57 Million
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $238,480 - $336,501	-18,778 Reduced 12.03%	137,300 $1.74 Million

Q2 2024 Aug 13, 2024	BUY	$12.72 - $19.2 $245,966 - $371,270	19,337 Added 14.14%	156,078 $2.62 Million
Q1 2024 May 15, 2024	BUY	$13.81 - $19.33 $1.89 Million - $2.64 Million	136,741 New	136,741 $2.05 Million
Q4 2023 Feb 12, 2024	BUY	$10.87 - $15.93 $1.14 Million - $1.67 Million	104,600 New	104,600 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $619,356 - $1.59 Million	70,063 New	70,063 $981,000
Q1 2022 May 16, 2022	SELL	$5.92 - $9.73 $1.41 Million - $2.32 Million	-238,008 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.03 - $19.13 $716,006 - $1.52 Million	-79,292 Reduced 24.99%	238,008 $2.26 Million
Q3 2021 Nov 15, 2021	SELL	$14.31 - $18.39 $15.3 Million - $19.7 Million	-1,072,325 Reduced 77.17%	317,300 $5.34 Million
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $4.03 Million - $5.55 Million	-264,958 Reduced 16.01%	1,389,625 $21.2 Million
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $3.35 Million - $5.02 Million	-186,054 Reduced 10.11%	1,654,583 $32.2 Million
Q4 2020 Feb 12, 2021	SELL	$17.54 - $25.43 $2.72 Million - $3.95 Million	-155,353 Reduced 7.78%	1,840,637 $33.2 Million
Q3 2020 Nov 16, 2020	SELL	$18.81 - $26.42 $105,373 - $148,004	-5,602 Reduced 0.28%	1,995,990 $38.5 Million
Q2 2020 Aug 14, 2020	BUY	$16.5 - $29.7 $15 Million - $26.9 Million	906,207 Added 82.73%	2,001,592 $52.3 Million
Q1 2020 May 14, 2020	SELL	$13.68 - $34.6 $1.72 Million - $4.36 Million	-126,012 Reduced 10.32%	1,095,385 $19.5 Million
Q4 2019 Feb 11, 2020	BUY	$21.11 - $34.86 $25.8 Million - $42.6 Million	1,221,397 New	1,221,397 $40.8 Million

Others Institutions Holding URGN

# of Institutions

171

Shares Held

43.8M

Call Options Held

1.61M

Put Options Held

433K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $553M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Uro Gen Pharma Ltd. Transaction History